YOR169C Antibody

What is YOR169C and why is it significant in yeast research?

YOR169C is a gene in Saccharomyces cerevisiae that encodes a protein with the UniProt accession number Q08540. This protein is significant in yeast research as it contributes to our understanding of fundamental cellular processes in eukaryotes. The YOR169C gene product is involved in specific cellular functions that make it a valuable target for researchers studying yeast as a model organism. Methodologically, researchers use YOR169C antibodies to detect, quantify, and localize this protein in various experimental contexts, providing insights into cellular mechanisms that may have broader implications for eukaryotic biology .

What experimental techniques are compatible with YOR169C Antibody?

YOR169C Antibody can be utilized in multiple experimental approaches, including:

• Western blotting (recommended dilution 1:500-1:2000)

• Immunoprecipitation (IP)

• Chromatin immunoprecipitation (ChIP)

• Immunofluorescence (IF)

• Enzyme-linked immunosorbent assay (ELISA)

For optimal results in Western blotting, researchers should use fresh cell lysates with protease inhibitors and optimize blocking conditions (typically 5% non-fat milk or BSA). For immunofluorescence, a fixation protocol using 4% paraformaldehyde followed by permeabilization with 0.1-0.5% Triton X-100 often yields the best results. The antibody compatibility with these techniques enables comprehensive analysis of YOR169C expression, localization, and interaction partners .

How should YOR169C Antibody be stored and handled to maintain activity?

To preserve antibody activity, YOR169C Antibody should be stored at -20°C for long-term storage, with aliquoting recommended to avoid repeated freeze-thaw cycles. When working with the antibody, it should be thawed on ice and centrifuged briefly before use to collect all liquid at the bottom of the tube. For short-term storage (1-2 weeks), the antibody can be kept at 4°C. When designing experiments, researchers should incorporate appropriate controls, including a no-primary antibody control and, ideally, samples from YOR169C knockout strains to validate specificity .

How can I optimize YOR169C Antibody concentration for Western blotting in difficult experimental conditions?

Optimizing YOR169C Antibody concentration for Western blotting in challenging conditions requires a systematic approach:

• Conduct a titration experiment using 1:500, 1:1000, 1:2000, and 1:5000 dilutions

• If signal is weak, implement the following enhancements:

  • Increase protein loading (up to 50-100 μg total protein)

  • Extend primary antibody incubation (overnight at 4°C)

  • Use a more sensitive detection system (e.g., ECL Prime or SuperSignal West Femto)

  • Add 0.05% SDS to antibody dilution buffer to reduce background

• For high background issues:

  • Increase blocking time (2-3 hours at room temperature)

  • Add 0.1-0.5% Tween-20 to wash buffers

  • Perform more extensive washing steps (5× 10 minutes)

These methodological adjustments should be documented and reported in research publications to facilitate reproducibility across laboratories .

What are the recommended controls for validating YOR169C Antibody specificity in immunofluorescence studies?

For rigorous validation of YOR169C Antibody specificity in immunofluorescence:

• Essential controls:

  • YOR169C deletion/knockout strain (negative control)

  • YOR169C overexpression strain (positive control)

  • Secondary antibody-only control (background assessment)

  • Pre-immune serum control (non-specific binding assessment)

• Advanced validation approaches:

  • Peptide competition assay using the immunizing peptide

  • Colocalization with a different antibody targeting the same protein

  • GFP-tagged YOR169C strain for comparative localization

• Quantification controls:

  • Include internal standards for fluorescence intensity

  • Perform Z-stack imaging to ensure complete cellular sampling

  • Implement blind scoring by multiple observers for localization patterns

Implementation of these controls ensures that observed signals genuinely represent YOR169C localization rather than artifacts or non-specific binding .

How do growth conditions affect YOR169C expression and antibody detection?

YOR169C expression varies significantly based on yeast growth conditions, which impacts antibody detection sensitivity:

When designing experiments, researchers should standardize growth conditions precisely and document them thoroughly in methodological sections. If comparing YOR169C expression across conditions, normalize to appropriate housekeeping proteins that remain stable under the tested conditions .

How can I use YOR169C Antibody to investigate protein-protein interactions through co-immunoprecipitation?

For effective co-immunoprecipitation (Co-IP) with YOR169C Antibody:

• Lysis buffer optimization:

  • Use a gentle lysis buffer (e.g., 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate)

  • Include protease inhibitors and phosphatase inhibitors if investigating phosphorylation-dependent interactions

  • Add 1-2 mM EDTA to inhibit metalloprotease activity

• Antibody coupling strategy:

  • Directly couple YOR169C Antibody to protein A/G beads using a chemical crosslinker (e.g., DMP or BS3)

  • Alternatively, use pre-coupled magnetic beads for cleaner results

  • 5-10 μg antibody per 1 mg total protein typically yields optimal results

• Validation and controls:

  • Perform reverse Co-IP with antibodies against suspected interaction partners

  • Include IgG control from the same species as YOR169C Antibody

  • Validate interactions through orthogonal methods (e.g., proximity ligation assay or yeast two-hybrid)

This methodological approach enables reliable identification of YOR169C interaction partners and can reveal functional protein complexes .

What are common issues when using YOR169C Antibody in ChIP experiments and how can they be resolved?

When performing Chromatin Immunoprecipitation (ChIP) with YOR169C Antibody, researchers encounter several challenges:

• Low enrichment issues:

  • Increase crosslinking time (15-20 minutes with 1% formaldehyde)

  • Optimize sonication conditions to generate 200-500 bp fragments

  • Increase antibody amount (10-15 μg per ChIP reaction)

  • Extend incubation time to overnight at 4°C with rotation

• High background problems:

  • Implement more stringent wash conditions (increase salt concentration in wash buffers)

  • Add a pre-clearing step with protein A/G beads

  • Use more specific elution conditions

  • Include additional negative controls (non-target genomic regions)

• Technical considerations:

  • Ensure cells are harvested at the appropriate growth phase

  • Verify chromatin fragmentation by agarose gel electrophoresis

  • Consider sequential ChIP (Re-ChIP) for co-occupancy studies

  • Use spike-in controls for quantitative ChIP experiments

By addressing these methodological aspects, researchers can obtain reliable ChIP data to elucidate YOR169C's interaction with chromatin and potential role in transcriptional regulation .

How does YOR169C Antibody perform in detecting post-translational modifications of the target protein?

YOR169C Antibody detection of post-translational modifications (PTMs) varies depending on the modification site and type:

For comprehensive PTM analysis, researchers should combine YOR169C Antibody with modification-specific detection methods. This may include phosphatase treatment controls, deubiquitinating enzyme treatments, or mass spectrometry validation of specific modifications .

How do I accurately quantify YOR169C expression across different experimental conditions?

For accurate quantification of YOR169C expression:

• Western blot quantification:

  • Use a digital imaging system with linear dynamic range

  • Prepare a standard curve with recombinant protein or dilution series

  • Normalize to multiple housekeeping proteins (e.g., PGK1, TDH3, and ACT1)

  • Report results as fold-change relative to control conditions

• Statistical considerations:

  • Perform at least three biological replicates

  • Apply appropriate statistical tests (e.g., t-test, ANOVA with post-hoc analysis)

  • Report variability (standard deviation or standard error)

  • Document any outlier exclusion criteria

• Advanced quantification approaches:

  • Consider using fluorescent secondary antibodies for wider dynamic range

  • Implement automated band detection software to reduce subjective bias

  • Include internal calibration standards on each gel

These methodological approaches ensure reliable quantification of YOR169C expression changes, particularly when examining stress responses or genetic perturbations .

How can I differentiate between specific and non-specific signals when using YOR169C Antibody?

Differentiating specific from non-specific signals requires systematic validation:

• Definitive validation approaches:

  • Compare wild-type with YOR169C deletion strains

  • Perform peptide competition assays with increasing concentrations of blocking peptide

  • Test antibody reactivity in YOR169C overexpression systems

• Technical strategies for reducing non-specific signals:

  • Optimize blocking conditions (test BSA vs. non-fat milk vs. casein)

  • Increase washing stringency (higher salt concentration, longer wash times)

  • Pre-absorb antibody with lysates from YOR169C deletion strains

  • Reduce primary antibody concentration

• Pattern recognition:

  • Specific YOR169C signal appears at the expected molecular weight (~X kDa)

  • Non-specific bands typically persist in knockout/deletion samples

  • Specific signals should respond predictably to experimental manipulations

Implementation of these approaches allows researchers to confidently identify genuine YOR169C signals and avoid misinterpreting experimental results based on non-specific binding .

What are the challenges in interpreting YOR169C localization data from different fixation methods?

Interpretation of YOR169C localization data requires consideration of fixation-dependent artifacts:

To address these challenges:

• Compare multiple fixation methods when establishing a new protocol

• Document fixation approach thoroughly in methods sections

• Consider confirmation with orthogonal approaches (e.g., biochemical fractionation)

• Be cautious when comparing results obtained with different fixation methods across studies

This methodological awareness prevents misinterpretation of fixation-dependent localization patterns and ensures reproducible results .

How can YOR169C Antibody be utilized in single-cell analysis techniques?

YOR169C Antibody can be integrated into emerging single-cell analysis platforms:

• Mass cytometry (CyTOF) applications:

  • Metal-conjugate the YOR169C Antibody (typically with lanthanide metals)

  • Optimize antibody concentration for signal-to-noise ratio

  • Include appropriate isotype controls

  • Combine with other metal-conjugated antibodies for multiplexed analysis

• Single-cell imaging approaches:

  • Adapt for microfluidic single-cell capturing devices

  • Optimize for high-content imaging platforms

  • Consider photoconvertible fluorophore conjugates for pulse-chase experiments

  • Implement machine learning algorithms for automated classification

• Methodological considerations:

  • Validate antibody performance in single-cell preparations

  • Develop robust normalization strategies

  • Establish minimum detection thresholds

  • Implement appropriate clustering algorithms for heterogeneity analysis

These advanced applications enable researchers to investigate cell-to-cell variability in YOR169C expression and localization, providing insights into population heterogeneity in yeast cultures .

What approaches can be used to study the temporal dynamics of YOR169C using the antibody?

To study temporal dynamics of YOR169C:

• Time-course experimental design:

  • Synchronize yeast cultures (e.g., alpha-factor arrest and release)

  • Sample at regular intervals (typically 15-30 minute increments)

  • Process all samples simultaneously for immunoblotting

  • Implement automated sampling devices for precision

• Advanced imaging approaches:

  • Use microfluidics combined with time-lapse microscopy

  • Apply FRAP (Fluorescence Recovery After Photobleaching) with fluorescently-labeled antibody fragments

  • Consider optogenetic approaches combined with immunofluorescence

  • Implement computational tracking algorithms for dynamic localization

• Degradation and synthesis studies:

  • Combine with protein synthesis inhibitors (e.g., cycloheximide)

  • Use proteasome inhibitors to assess turnover rates

  • Implement pulse-chase labeling with subsequent immunoprecipitation

  • Quantify with absolute protein standards for accurate determination

These methodological approaches reveal the dynamic behavior of YOR169C in response to environmental changes, cell cycle progression, or genetic perturbations .

How might YOR169C Antibody be adapted for super-resolution microscopy techniques?

Adapting YOR169C Antibody for super-resolution microscopy requires specific modifications:

• STORM/PALM considerations:

  • Conjugate with photoswitchable fluorophores (e.g., Alexa Fluor 647)

  • Optimize labeling density (typically lower than conventional imaging)

  • Use secondary antibodies with multiple small fluorophores

  • Implement appropriate drift correction standards

• STED microscopy optimization:

  • Select antibody conjugates with appropriate photostability

  • Optimize fixation to minimize sample deformation

  • Consider using Fab fragments for reduced displacement

  • Implement multicolor STED with carefully selected fluorophore pairs

• Technical adaptations:

  • Optimize buffer conditions for photoswitching

  • Use fiducial markers for precise alignment

  • Implement specific mounting media to reduce oxygen

  • Consider DNA-PAINT approaches for maximum localization precision

These advanced imaging approaches enable visualization of YOR169C distribution at nanometer-scale resolution, potentially revealing previously undetectable structural arrangements and protein complexes .